Vaccine

CBRE Names Seattle Top Hub for Life Sciences Industry, VC Funding

In the second quarter of 2020, the city’s life sciences industry received $613.5 million in venture capital funding

COVID-19, pandemic, Coronavirus, Life Science, Vaccine